Document Detail


C-reactive protein and other inflammatory biomarkers as predictors of outcome following acute coronary syndromes.
MedLine Citation:
PMID:  15199444     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Despite diagnostic and therapeutic advances, the rate of event recurrence is still relatively high and short- and long-term prediction of risk is necessary although extremely challenging to provide optimal treatment to patients with acute coronary syndromes. Available data recommend the use of C-reactive protein (CRP) as a prognostic marker in patients with acute coronary syndromes in addition to other prognostic factors including troponin levels. Evaluation of CRP levels at time of admission should be included in the evaluation of the patient's risk profile, including clinical data, associated diseases, markers of myocardial necrosis (especially troponin levels), left ventricle performance, and age. A cutoff level of 10 mg/L for CRP may be used as a marker of higher risk for death and possibly myocardial infarction in acute coronary syndromes, and a cutoff of 3 mg/L identifies a group of patients with intermediate risk and a high rate of recurrent events.
Authors:
Antonio Abbate; Giuseppe G L Biondi-Zoccai; Salvatore Brugaletta; Giovanna Liuzzo; Luigi M Biasucci
Related Documents :
19838504 - Movement-induced heart rate changes in epileptic and non-epileptic seizures.
24296394 - Mid-ventricular tako-tsubo cardiomyopathy with structurally normal coronary arteries co...
12143944 - Long-term, continuous treatment with both oral and transdermal nitrates increases cardi...
17659924 - Usefulness of stress cardiac single-photon emission computed tomographic imaging late a...
20350504 - The impact of chronic kidney disease as a predictor of major cardiac events in patients...
15864804 - Method for coronary angiography in morbidly obese patients.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Seminars in vascular medicine     Volume:  3     ISSN:  1528-9648     ISO Abbreviation:  Semin Vasc Med     Publication Date:  2003 Nov 
Date Detail:
Created Date:  2004-06-16     Completed Date:  2004-07-29     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  100940307     Medline TA:  Semin Vasc Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  375-84     Citation Subset:  IM    
Affiliation:
Department of Cardiovascular Medicine, Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angina, Unstable / diagnosis*,  therapy
Biological Markers / blood
C-Reactive Protein / metabolism*
Humans
Inflammation / diagnosis*,  therapy
Myocardial Infarction / diagnosis*,  therapy
Predictive Value of Tests
Prognosis
Recurrence
Risk Assessment
Syndrome
Troponin / blood
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Troponin; 9007-41-4/C-Reactive Protein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Troponins in acute coronary syndromes.
Next Document:  Glycoprotein IIb/IIIa antagonists in acute coronary syndromes: where are we now?